Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors

C Simoens, PPL Martin‐Hirsch - Cochrane database of …, 2018 - cochranelibrary.com
Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …

[HTML][HTML] HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection

MR Timbang, MW Sim, AF Bewley… - Human vaccines & …, 2019 - Taylor & Francis
The incidence of oropharyngeal cancer (OPC) related to infection with human
papillomavirus (HPV) is rising, making it now the most common HPV-related malignancy in …

Safety of human papillomavirus vaccines: an updated review

A Phillips, C Patel, A Pillsbury, J Brotherton… - Drug safety, 2018 - Springer
Human papillomavirus (HPV) vaccines are now included in immunisation programmes in 71
countries. Unfortunately, uptake has been impacted in some countries by reduced …

[HTML][HTML] Relationship between human papillomavirus and penile cancer—implications for prevention and treatment

LC Kidd, S Chaing, J Chipollini… - Translational …, 2017 - ncbi.nlm.nih.gov
Penile cancer is a rare disease in the United States, but rates are increasing, causing
concern. Several risk factors have been associated with the disease, including human …

Advances in designing and developing vaccines, drugs and therapeutic approaches to counter human papilloma virus

M Dadar, S Chakraborty, K Dhama, M Prasad… - Frontiers in …, 2018 - frontiersin.org
Human papillomavirus (HPV) is a viral infection with skin-to-skin based transmission mode.
HPV annually caused over 500,000 cancer cases including cervical, anogenital and …

Quadrivalent human papillomavirus (HPV) vaccine induces HPV-specific antibodies in the oral cavity: results from the mid-adult male vaccine trial

LA Pinto, TJ Kemp, BN Torres… - The Journal of …, 2016 - academic.oup.com
Background. Human papillomavirus virus type 16 (HPV-16) and HPV-18 cause a large
proportion of oropharyngeal cancers, which are increasing in incidence among males, and …

Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years

I Maldonado, M Plata, M Gonzalez… - Human Vaccines & …, 2022 - Taylor & Francis
ABSTRACT Among women aged 27–45 years, the quadrivalent human papillomavirus
(qHPV; HPV6/11/16/18) vaccine was generally well tolerated, efficacious, and immunogenic …

Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults

I LeFevre, L Bravo, N Folschweiller, EL Medina… - npj Vaccines, 2023 - nature.com
Immunobridging is an important methodology that can be used to extrapolate vaccine
efficacy estimates to populations not evaluated in clinical studies, and that has been …

Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapies

PE Spiess, J Dhillon, AS Baumgarten… - CA: A Cancer …, 2016 - Wiley Online Library
Answer questions and earn CME/CNE Squamous cell carcinoma (SCC) of the penis is a
rare malignancy in the United States, with a significantly higher incidence—up to 20 to 30 …

Human papillomavirus-associated head and neck cancer

JC Nogues, S Fassas, C Mulcahy… - The Journal of the …, 2021 - Am Board Family Med
Oropharyngeal squamous cell carcinoma (OPSCC) has historically been attributable to
tobacco and alcohol exposure and saw a decline in incidence after societal norms shifted …